BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31361991)

  • 1. New markers in ulcerative colitis.
    Nakov R
    Clin Chim Acta; 2019 Oct; 497():141-146. PubMed ID: 31361991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis.
    Shinzaki S; Matsuoka K; Iijima H; Mizuno S; Serada S; Fujimoto M; Arai N; Koyama N; Morii E; Watanabe M; Hibi T; Kanai T; Takehara T; Naka T
    J Crohns Colitis; 2017 Jan; 11(1):84-91. PubMed ID: 27466171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ulcerative Colitis Response Index for Detection of Mucosal Healing in Patients Treated With Anti-tumour Necrosis Factor.
    de Bruyn M; Ringold R; Martens E; Ferrante M; Van Assche G; Opdenakker G; Dukler A; Vermeire S
    J Crohns Colitis; 2020 Feb; 14(2):176-184. PubMed ID: 31628842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucine-rich alpha-2 glycoprotein 1, high mobility group box 1, matrix metalloproteinase 3 and annexin A1 as biomarkers of ulcerative colitis endoscopic and histological activity.
    Kourkoulis P; Michalopoulos G; Katifelis H; Giannopoulou I; Lazaris AC; Papaconstantinou I; Karamanolis G; Gazouli M
    Eur J Gastroenterol Hepatol; 2020 Sep; 32(9):1106-1115. PubMed ID: 32483088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis.
    de Bruyn M; Arijs I; Wollants WJ; Machiels K; Van Steen K; Van Assche G; Ferrante M; Rutgeerts P; Vermeire S; Opdenakker G
    Inflamm Bowel Dis; 2014 Jul; 20(7):1198-207. PubMed ID: 24871805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
    Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
    Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test.
    Takashima S; Kato J; Hiraoka S; Nakarai A; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H; Tanaka T; Yamamoto K
    Am J Gastroenterol; 2015 Jun; 110(6):873-80. PubMed ID: 25823769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis.
    Hassan EA; Ramadan HK; Ismael AA; Mohamed KF; El-Attar MM; Alhelali I
    Saudi J Gastroenterol; 2017; 23(4):238-245. PubMed ID: 28721978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis.
    Nielsen OH; Gionchetti P; Ainsworth M; Vainer B; Campieri M; Borregaard N; Kjeldsen L
    Am J Gastroenterol; 1999 Oct; 94(10):2923-8. PubMed ID: 10520846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome.
    Toyonaga T; Kobayashi T; Nakano M; Saito E; Umeda S; Okabayashi S; Ozaki R; Hibi T
    PLoS One; 2017; 12(9):e0185131. PubMed ID: 28934315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum human trefoil factor 3 is a biomarker for mucosal healing in ulcerative colitis patients with minimal disease activity.
    Srivastava S; Kedia S; Kumar S; Pratap Mouli V; Dhingra R; Sachdev V; Tiwari V; Kurrey L; Pradhan R; Ahuja V
    J Crohns Colitis; 2015 Jul; 9(7):575-9. PubMed ID: 25964429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial.
    Langhorst J; Boone J; Lauche R; Rueffer A; Dobos G
    J Crohns Colitis; 2016 Jul; 10(7):786-94. PubMed ID: 26874351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
    Mak WY; Buisson A; Andersen MJ; Lei D; Pekow J; Cohen RD; Kahn SA; Pereira B; Rubin DT
    Dig Dis Sci; 2018 May; 63(5):1294-1301. PubMed ID: 29468374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
    Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
    Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of endoscopic assessment of inflammation in ulcerative colitis: Can endoscopic evaluation predict outcomes?
    Mohammed N; Subramanian V
    World J Gastroenterol; 2016 Nov; 22(42):9324-9332. PubMed ID: 27895420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution.
    Díaz-Jiménez D; De la Fuente M; Dubois-Camacho K; Landskron G; Fuentes J; Pérez T; González MJ; Simian D; Hermoso MA; Quera R
    BMC Gastroenterol; 2016 Aug; 16(1):103. PubMed ID: 27565556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications.
    Muthas D; Reznichenko A; Balendran CA; Böttcher G; Clausen IG; Kärrman Mårdh C; Ottosson T; Uddin M; MacDonald TT; Danese S; Berner Hansen M
    Scand J Gastroenterol; 2017 Feb; 52(2):125-135. PubMed ID: 27610713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
    Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease.
    Palone F; Vitali R; Cucchiara S; Pierdomenico M; Negroni A; Aloi M; Nuti F; Felice C; Armuzzi A; Stronati L
    Inflamm Bowel Dis; 2014 Aug; 20(8):1448-57. PubMed ID: 24983978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anterior Gradient Protein 2 Promotes Mucosal Repair in Pediatric Ulcerative Colitis.
    Ye X; Wu J; Li J; Wang H
    Biomed Res Int; 2021; 2021():6483860. PubMed ID: 34055987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.